Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1993]
News [3240]
Articles [134]
Editorials [3]
Conferences [122]
elearning [18]
T cell immunotherapy for leukaemia in preclinical setting
Dr Michael Kalos - University of Pennsylvania, Philadelphia, USA
T cell immunotherapy for leukaemia in preclinical setting ( Dr Michael Kalos - University of Pennsylvania, Philadelphia, USA )
17 Dec 2013
Idelalisib and rituximab for previously treated chronic lymphocytic leukaemia...
Dr Richard Furman - New York Weill Cornell Medical Center, USA
Idelalisib and rituximab for previously treated chronic lymphocytic leukaemia (CLL) ( Dr Richard Furman - New York Weill Cornell Medical Center, USA )
17 Dec 2013
Gemtuzumab improves event free survival for paediatric acute myeloid leukaemia...
Dr Alan Gamis - University of Missouri-Kansas City School of Medicine, USA
Gemtuzumab improves event free survival for paediatric acute myeloid leukaemia (AML) ( Dr Alan Gamis - University of Missouri-Kansas City School of Medicine, USA )
17 Dec 2013
Comment: Transplantation and short telomeres increase the risk of cognitive...
Dr Jeffrey Miller - University of Minnesota, Minneapolis, USA
Comment: Transplantation and short telomeres increase the risk of cognitive impairment ( Dr Jeffrey Miller - University of Minnesota, Minneapolis, USA )
17 Dec 2013
Equality of access to transplant for ethnic minority patients
Dr Robert Lown - Royal Marsden Hospital, London, UK
Equality of access to transplant for ethnic minority patients ( Dr Robert Lown - Royal Marsden Hospital, London, UK )
17 Dec 2013
New agents in CLL
Dr Jacqueline Barrientos - LIJ Medical Center, New York, USA
New agents in CLL ( Dr Jacqueline Barrientos - LIJ Medical Center, New York, USA )
13 Dec 2013
Full-intensity transplantation and short telomeres increase risk of cognitive...
Dr Smita Bhatia - City of Hope National Medical Center, Duarte, USA
Full-intensity transplantation and short telomeres increase risk of cognitive impairment after allogeneic haematopoietic cell transplantation ( Dr Smita Bhatia - City of Hope National Medical Center, Duarte, USA )
13 Dec 2013
Targeting tyrosine kinase receptors to tackle CML
Prof Michael Deininger - University of Utah, Salt Lake City, USA
Targeting tyrosine kinase receptors to tackle CML ( Prof Michael Deininger - University of Utah, Salt Lake City, USA )
13 Dec 2013
Chronic lymphocytic leukaemia: A new treatment era is born
Dr John Gribben - Barts Cancer Institute, London, UK
Chronic lymphocytic leukaemia: A new treatment era is born ( Dr John Gribben - Barts Cancer Institute, London, UK )
13 Dec 2013
Chemo-free treatment for acute promyelocytic leukaemia
Dr Luca Mazzarella - European Institute of Oncology, Milan, Italy
Chemo-free treatment for acute promyelocytic leukaemia ( Dr Luca Mazzarella - European Institute of Oncology, Milan, Italy )
13 Dec 2013
Initial phase III results of the first trial in newly diagnosed multiple myeloma
Dr Thierry Facon - Centre Hospitalier Régional Universitaire de Lille, France
Initial phase III results of the first trial in newly diagnosed multiple myeloma ( Dr Thierry Facon - Centre Hospitalier Régional Universitaire de Lille, France )
10 Dec 2013
Lenalidomide promotes CRBN-mediated ubiquitination and degradation of IKZF1 and...
Dr Jan Krönke - Brigham and Women's Hospital, Boston, USA
Lenalidomide promotes CRBN-mediated ubiquitination and degradation of IKZF1 and IKZF3 ( Dr Jan Krönke - Brigham and Women's Hospital, Boston, USA )
8 Dec 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation